Efficacy of agomelatine versus venlafaxine on subjective sleep of patients with major depressive disorder

被引：0
|
作者：
Guilleminault, C [1 ]
机构：
[1] Sleep Disorder Clin, Stanford, CA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S419 / S420
页数：2
相关论文
共 50 条
  • [31] Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response
    Papakostas, George, I
    Nielsen, Rebecca Z.
    Dragheim, Marianne
    Tonnoir, Brigitte
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 101 : 72 - 79
  • [32] Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder
    Kennedy, Sidney H.
    Grouin, Jean-Marie
    Cadour, Stephanie
    Robert, Veronique
    Picarel-Blanchot, Francoise
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2018, 33 (01)
  • [33] Major depressive disorder, sleep EEG and agomelatine: an open-label study
    Salva, Maria-Antonia Quera
    Vanier, Bernard
    Laredo, Judith
    Hartley, Sarah
    Chapotot, Florian
    Moulin, Catherine
    Lofaso, Frederic
    Guilleminault, Christian
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05): : 691 - 696
  • [34] Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder
    Mcintyre, Roger S.
    Agid, Ofer
    Biesheuvel, Egbert
    Purushottamahanti, Pradeep
    [J]. CNS SPECTRUMS, 2024, 29 (03) : 206 - 214
  • [35] Comparison of the effects of sertraline and agomelatine on sleep quality, sexual functioning and metabolic parameters in patients with major depressive disorder
    Talas, Anil
    Cerit, Cem
    Aslan, Esma Akpinar
    [J]. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 29 (03) : 257 - 263
  • [36] Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
    Fernandez, JL
    Montgomery, S
    Francois, C
    [J]. PHARMACOECONOMICS, 2005, 23 (02) : 155 - 167
  • [37] Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
    José-Luis Fernandez
    Stuart Montgomery
    Clément Francois
    [J]. PharmacoEconomics, 2005, 23 : 155 - 167
  • [38] Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity
    Lyndon, Gavin J.
    Prieto, Rita
    Wajsbrot, Dalia B.
    Allgulander, Christer
    Bandelow, Borwin
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (03) : 110 - 118
  • [39] The efficacy, of venlafaxine vs. SSRIs in panic disorder and major depressive disorder dual diagnosis
    Vasile, D.
    Vasiliu, O.
    Stanescu, B.
    Bancescu, R.
    Terpan, M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 284 - 285
  • [40] Sustained efficacy and safety of agomelatine versus placebo over 24 weeks in elderly out-patients suffering from major depressive disorder
    Heun, R.
    Corral, R.
    Ahokas, A.
    Nicolini, H.
    Teixeira, J. M.
    Dehelean, P.
    Picarel-Blanchot, F.
    De Bodinat, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S403 - S404
12345